X-Aptamer Selection and Validation
Aptamers and second generation analogs, such as X-Aptamers (XAs), SOMAmers, locked nucleic acids (LNAs), and others are increasingly being used for molecular pathway targeting, biomarker discovery, or disease diagnosis by interacting with protein targets on the surface of cells or in solution. Such targeting is being used for imaging, diagnostic evaluation, interference of protein function, or delivery of therapeutic agents. Selection of aptamers using the original SELEX method is cumbersome and time-consuming, often requiring 10–15 rounds of selection, and provides aptamers with a limited number of functional groups, namely four bases of DNA or RNA, although newer SELEX methods have increased this diversity. In contrast, X-Aptamers provide an unlimited number of functional groups and thus are superior targeting agents. Here, we discuss the X-Aptamer selection process.
Key wordsAptamer X-Aptamer Molecular targeting Biotin labeling Dye labeling Bead-based selection Split-pool synthesis Drug aptamer conjugation Aptamer nanoparticle conjugation Aptamer siRNA chimeras Chemical cross-linking Proteomics
- 11.Koshkin AA, Singh SK, Nielsen P, Rajwanshi VK, Kumar R, Meldgaard M, Olsen CE, Wengel J (1998) LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron 54(14):3607–3011CrossRefGoogle Scholar
- 12.Rhie A, Kirby L, Sayer N, Wellesley R, Disterer P, Sylvester I, Gill A, Hope J, William James W, Tahiri-Alaoui A (2003) Characterization of 2′-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J Biol Chem 278:39697–39705CrossRefPubMedGoogle Scholar
- 23.He W, Elizondo-Riojas M-A, Li X, Lokesh GLR, Somasunderam A, Thiviyanathan V, Volk DE, Durland RH, Englehardt J, Cavasotto CN, Gorenstein DG (2012) X-Aptamers: a bead-based selection method for random incorporation of drug-like moieties onto next-generation aptamers for enhanced binding. Biochemistry 51(42):8321–8323CrossRefPubMedPubMedCentralGoogle Scholar
- 29.Yang X, Bassett SE, Li X, Luxon BA, Herzog NK, Shope RE, Aronson J, Prow TJ, Leary JF, Kirby R, Ellington AD, Gorenstein DG (2002) Construction and selection of bead-bound combinatorial oligonucleotide phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing. Nucleic Acids Res 30:e132CrossRefPubMedPubMedCentralGoogle Scholar